386 related articles for article (PubMed ID: 11884611)
1. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway.
Perrotti D; Iervolino A; Cesi V; Cirinná M; Lombardini S; Grassilli E; Bonatti S; Claudio PP; Calabretta B
Mol Cell Biol; 2000 Aug; 20(16):6159-69. PubMed ID: 10913197
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
Eiring AM; Neviani P; Santhanam R; Oaks JJ; Chang JS; Notari M; Willis W; Gambacorti-Passerini C; Volinia S; Marcucci G; Caligiuri MA; Leone GW; Perrotti D
Blood; 2008 Jan; 111(2):816-28. PubMed ID: 17925491
[TBL] [Abstract][Full Text] [Related]
4. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D
Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
6. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.
Notari M; Neviani P; Santhanam R; Blaser BW; Chang JS; Galietta A; Willis AE; Roy DC; Caligiuri MA; Marcucci G; Perrotti D
Blood; 2006 Mar; 107(6):2507-16. PubMed ID: 16293596
[TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins.
Perrotti D; Calabretta B
Oncogene; 2002 Dec; 21(56):8577-83. PubMed ID: 12476304
[TBL] [Abstract][Full Text] [Related]
8. Distinct RNP complexes of shuttling hnRNP proteins with pre-mRNA and mRNA: candidate intermediates in formation and export of mRNA.
Mili S; Shu HJ; Zhao Y; Piñol-Roma S
Mol Cell Biol; 2001 Nov; 21(21):7307-19. PubMed ID: 11585913
[TBL] [Abstract][Full Text] [Related]
9. Transcription-dependent nucleocytoplasmic distribution of hnRNP A1 protein in early mouse embryos.
Vautier D; Chesné P; Cunha C; Calado A; Renard JP; Carmo-Fonseca M
J Cell Sci; 2001 Apr; 114(Pt 8):1521-31. PubMed ID: 11282028
[TBL] [Abstract][Full Text] [Related]
10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous Nuclear Ribonucleoprotein A1 and Lamin A/C Modulate Nucleocytoplasmic Shuttling of Avian Reovirus p17.
Chiu HC; Huang WR; Wang YY; Li JY; Liao TL; Nielsen BL; Liu HJ
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375578
[TBL] [Abstract][Full Text] [Related]
12. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B
EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511
[TBL] [Abstract][Full Text] [Related]
13. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
[TBL] [Abstract][Full Text] [Related]
14. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
Chu S; McDonald T; Bhatia R
Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
[TBL] [Abstract][Full Text] [Related]
15. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
Tavor S; Park DJ; Gery S; Vuong PT; Gombart AF; Koeffler HP
J Biol Chem; 2003 Dec; 278(52):52651-9. PubMed ID: 14517214
[TBL] [Abstract][Full Text] [Related]
16. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines.
Jonuleit T; van der Kuip H; Miething C; Michels H; Hallek M; Duyster J; Aulitzky WE
Blood; 2000 Sep; 96(5):1933-9. PubMed ID: 10961897
[TBL] [Abstract][Full Text] [Related]
17. AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and the cytoplasm.
Katz DA; Theodorakis NG; Cleveland DW; Lindsten T; Thompson CB
Nucleic Acids Res; 1994 Jan; 22(2):238-46. PubMed ID: 8121809
[TBL] [Abstract][Full Text] [Related]
18. Control of nuclear export of hnRNP A1.
Lichtenstein M; Guo W; Tartakoff AM
Traffic; 2001 Apr; 2(4):261-7. PubMed ID: 11285136
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
Kim JH; Hahm B; Kim YK; Choi M; Jang SK
J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL activates mdm2 mRNA translation via the La antigen.
Trotta R; Vignudelli T; Candini O; Intine RV; Pecorari L; Guerzoni C; Santilli G; Byrom MW; Goldoni S; Ford LP; Caligiuri MA; Maraia RJ; Perrotti D; Calabretta B
Cancer Cell; 2003 Feb; 3(2):145-60. PubMed ID: 12620409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
